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In this study, we tried to understand better the association of oxidative stress and inflammation with type-2 diabetes and 
diabetic nephropathy to provide a basis for investigating improved diagnostic possibilities, treatment and prevention of the 
disease. Blood samples were collected from 498 West Indian individuals aged 42–72 years. Differences in the level of 
oxidative stress markers (MDA, GSH, SOD and CAT) and inflammation (TNF-α and IL1-α) was determined in patients 
(type 2 diabetic and diabetic nephropathy) and control participants. Patients with nephropathy showed significantly 
decreased SOD, GSH levels, but significantly increased MDA and CAT activity compared to DM patients as well as 
controls. Significant higher level of expression of TNF-α and IL1-α (P< 0.05) was observed in DM and DN patients as 
compared to controls. The results suggest that oxidative stress and inflammation are triggered in patients of type 2 diabetes 
and diabetic nephropathy possibly due to hyperglycemia.  
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Type 2 Diabetes mellitus (DM) has become a major 
global health problem. It is one of the serious 
devastating diseases found in endemic proportion and 
the frequency of DM patients is expected to go even 
higher in the future. Long term hyperglycemia in DM 
results in DN and if DM is not treated on time
1
. DN is a 
progressive complication of DM which takes several 
years for development. It includes unusual functional 
clinical abnormalities of the kidney such as eminent 
creatinine, urea, albuminuria, reduced glomerular 
filtration rate, hypertension and fluid retention rate
2
. DN 
may lead to severe complications like End Stage Renal 
Disease (ESRD) and patients of DN will have to 
undergo hemodialysis. The frequency of reported ESRD 
was 4.0-4.3% with type-1 diabetes mellitus and  
4.5-4.7% with DM. The pathogenesis of DN is 
complicated and comprises many factors like time-
interval of DM, deprived glucose control, oxidative 
stress, high blood pressure and hyper tri-glyceridemia
3
.  
Oxidative stress can be defined as disruption flanked 
by pro- and anti-oxidant factors that fallout in  
tissue damage. It is found that many pathological 
conditions are result of increase in oxidative stress  
and it is believed that it functions as a major pathogenic 
factor in many of these conditions. Oxidative stress  
is suggested to be an essential factor in the 
development and progression of DM as well as in  
the development of diabetic complications like DN
4-7
. 
The principal mechanism in the onset of DM are still 
complex because hyperglycemia may be both root 
source and outcome of increased oxidative stress
8,9
. 
There has been a recent notion that inflammation and 
activation of the innate immune system are  
closely involved in the pathogenesis of DN
10,11
.  
Oxi-flammation (i.e. oxidative stress and 
inflammation) influence multiple cellular responses  
in different organ system are associated with chronic 
inflammatory mechanism
12,13
. The constructive 
feedback cycle concerning persistence inflammation, 
oxidative stress, and development of insulin-resistance 
contribute to several diabetes-linked consequences such 
as cardiovascular diseases, kidney diseases and several 
types of cancer
14
. Various studies proved noteworthy 
role of inflammatory molecules like chemokines, 
cytokines and adhesion molecules in the pathogenesis  
of DN
15,16
. 
—————— 
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In spite of the improvement in our knowledge about 
the pathogenesis of DN, the intricate mechanisms 
leading from long term hyperglycemic condition to the 
development of DN is yet not completely known. As 
hyperglycemic condition is well-known to trigger both 
oxidative stress and inflammatory pathways, the 
connections of these two pathways are recommended 
to act in the hyperglycemia mediated renal damage. 
These findings have stimulated the exploration for an 
intent biomarker of oxidative stress and inflammation 
which might be clinically useful in patients with  
DM and DN. This study aims to enhance the 
understanding of the link between oxidative stress, 
inflammation and DN. To achieve this, differences in 
the level of biochemical markers of oxidative stress and 
inflammation were determined in patients suffering 
from DM and DN. 
 
Methods 
 
Selection of cases 
This study was carried out in Indian participants 
specially residing towards western region. They were 
further divided into four groups: 1) healthy control 
(n=153), 2) DM (n=128), 3) DN (n=102) and 4) NDN 
(n=115). Diagnosis of diabetes mellitus was based on 
the recommendation of American Diabetes 
Association (ADA). Duration of DM was considered 
as the time from which the patient was diagnosed with 
DM. Nephropathy was diagnosed on the basis of 
persistent GFR <80 mL/min per 1.73 m2. Other 
baseline criteria included urinary protein excretion 
>0.05 g/kg per 24 h with hypoalbuminaemia <25 g/L 
in diabetic and non-diabetic. This study was approved 
by institutional ethical committee of G.J. Patel 
Ayurvedic College, Vallabh Vidyanagar, Gujarat. The 
purpose of this study was properly explained to every 
participant and informed consent forms were signed 
before carrying out the study. 
 
Estimation of oxidative stress markers 
The blood samples were collected from each 
participant in EDTA coated Vacutainer tube. After 
centrifugation at 4000 rpm for 8 min, the plasma and 
buffy coat were removed to collect the red blood cells 
(RBC).  
 
Glutathione (GSH) estimation 
Estimation of GSH from blood samples was carried 
out using slightly modified Khyanriam and Prasad 
method
17
. 100ul of blood, 0.5 mL water and 1 mL 
precipitating solution (glacial metaphosphoric acid 
1.7 g, sodium EDTA 0.2 g, NaCl 30 g in 100 mL of 
water) were added and mixed well for 10 min of 
incubation at room temperature. The reaction mixture 
was centrifuged (4000 g for 10 min). To the 400 µL 
of clear supernatant, 1 mL of 0.3 mol/L phosphate 
solution and 200 µL DTNB solution were added. 
Blank and sample reaction mixtures were read against 
415 nm in spectrophotometer. 
 
Malondialdehyde (MDA) estimation 
MDA was estimated by using modified method of 
Mossa et al.
18
. 250 microliters (µL) of serum and  
250 µL of 50% trichloroacetic acid (TCA) were added 
mixed until the proteins precipitated. Samples were 
centrifuged at 9000 rpm for 3 min. To the 150 µL of 
supernatant 150 µL of thiobarbituric acid (TBA) and 
samples were incubated in boiling water bath for 20 min. 
The colored product due to reaction of TBA with MDA 
was measured spectrophotometrically at 530 nm.  
 
Estimation of CAT activity 
CAT activity was determined using modified 
procedure of Goth et al.
19
. 0.5 mL of serum and 2 mL 
of substrate solution (60 pmol/mL hydrogen peroxide 
(H2O2) in 50 mM/L sodium-potassium phosphate 
buffer, pH 7.4) were incubated at room temperature for 
1 min. The reaction was stopped with 0.7 mL of 
ammonium molybdate and the yellow colored complex 
formed was measured at 400 nm against blank.  
 
Estimation of Superoxide dismutase (SOD) activity 
The SOD activity was estimated using modified 
method of Madesh and Balasubramanian .
20
. To 0.5 mL 
of serum 1.5 mL of reaction mixture was added  
1.5 mL of (0.052 mM) sodium pyrophosphate buffer, 
0.2 mL of (185 mM) phenazine methosulphate,  
0.5 mL of 300 mM nitro blue tetrazolium (NBT). 
Enzymatic reaction was initiated by adding 0.5 mL of 
NADH and stopped by adding 1.2 mL of glacial 
acetic acid. Colour product was measured at 560 nm 
using spectrophotometrically. 
 
Determination of expression level of inflammatory markers 
(IL1-α and TNF-α) by qRT-PCR 
Expression level of IL1-α and TNF-α in DM, DN and 
NDN was checked against control. Total RNA was 
extracted using Trizol method
21
. cDNA synthesis was 
performed using sample mix 13.5 µL (1 µL template 
RNA, 1 µL oligo dT and 11.5 µL MilliQ) and reaction 
mix 6.5 µL (1 µL reverse transcriptase, 0.5 µL 
riboblock, 1 µL dNTPs, 4 µL RT buffer) according to 
standard procedures. Expression analysis was performed 
with the help of quantitative real-time polymerase chain 
reaction (qRT-PCR) (Rotor gene 6000, Corbett 
research). The primers used were: human IL1-α forward: 
5-TTGGTGCACATGGCAAGTGGAACGACGCCC 
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TCAATCA AA-3; reverse: 5-GCACAGTCAAGG 
CTATTTTTCCAGGGCTC GACTCCTTCAT-3 and 
human TNF-α forward: 5-CGGTGGTGGGACTCGTA 
TGCAAGTAACAAGCCGGTAGCC-3; reverse: 5-
CTGGTTGTCTTCCAGCTTCACATGGAAGACTCC
TCCCTGGTA-3. The values were normalized against 
the housekeeping genes GAPDH (glyceraldehyde- 
3-phosphate dehydrogenase).  
 
Statistical evaluation 
The data obtained were analyzed statistical  
using SPSS version 21.0. All data are presented as 
mean ± S.D. Statistical analysis was done by using 
student’s t-test. The statistical t-test was considered 
significant with a P-value of 0.05 or less.  
 
Results and Discussion 
In the present study we carried out case-control 
studies, to understand the role of oxidative stress 
markers in diabetes and diabetic nephropathy in 
Indian population. The clinical details of control, DM, 
DN and NDN subjects are summarized in (Table 1). 
The mean age of the control subject (44±11.2) was 
non-significantly lower than the DM (52±7.3) or DN 
(58±12.5) or NDN (51±12.3). We found no 
significant difference in body mass index (BMI), 
systolic and diastolic blood pressure in all the three 
studied groups of patients in compare to control. 
However, glycosylated haemoglobin (HbA1c) in 
NDN patients and in DN were significantly (P< 0.05) 
higher than control subjects. Whereas, serum 
creatinine level of was significantly greater in NDN 
and DN (P< 0.05) as compared to DM and control. 
Many experimental studies suggested the major 
role of oxidative stress in the pathogenesis of DM and 
DN. Increased production of ROS in diabetes may be 
one of the common mechanisms of diabetic vascular 
complications like DN. Therefore, evaluation of the 
oxidative stress production is essential for the 
prediction and prevention of DN
22
. The assessment of 
lipid peroxidation status is found to be evidence of 
cellular oxidative stress. Majority of membrane 
phospholipids are easily oxidized
23
. It results into the 
formation of lipid peroxides which are decomposed to 
aldehydes like MDA
24
. The present study revealed a 
significant increase in MDA production in patients’ 
group compared to control as shown in (Table 2)  
Table 1 — Clinical and biochemical characteristics of studied subjects 
Variables Control DM DN NDN 
Number (n) 153 128 102 115 
Age (years) 44±11.2 52±7.3 58±12.5 51±12.3 
BMI (kg/m²) 20.7±2.5 23.5±2.5 23.6±2.4 21.8±1.5 
HbA1c (%) 4.39±0.9 7.12±1.2* 8.56±1.2* 5.22±1.2 
Diabetic Duration (years) - 5.6±3.3 12.13±4.0 - 
SBP (mm Hg) 138.5±8.1 147.3±11.3 149.25±12.5 140.35±10.9 
DBP (mm Hg) 91.33±5.3 95.54±7.3 96.22±8.1 92.01±7.1 
Creatinine (mg/dL) 0.56±0.6 0.83±0.6 4.23±0.4*# 3.87±0.8* 
Cholesterol (mg/dL) 162.48±5.3 180.83±6.3 191.76±6.3 181.38±5.1 
LDL (mg/dL) 102.65±4.5 117.45±3.2 124.54±4.4 110.31±6.3 
Data are expressed as mean ± SD; * P< 0.05 when compared to control, # P< 0.05 when compared to DM 
 
Table 2 — Oxidative stress markers in control and patients group 
Groups MDA (M/L) % Change GSH (mg/mL) % Change SOD (U/mL) % Change CAT (U/mL) % Change 
Control(143) 35.75±0.53 - 0.71±0.01 - 17.11±0.32 - 62.62±0.66 - 
DM (103) 38.29±0.41 
P< 0.05a 
+107.10a 0.68±0.01 
P> 0.05a 
−95.77a 13.69±0.27 
P< 0.05a 
−80.01a 65.31±1.03 
P< 0.05a 
+104.29a 
DN (102) 49.39±0.78 
P< 0.05a 
P< 0.05b 
+138.15a 
+128.98b 
0.53±0.01 
P< 0.05a 
P< 0.05b 
−74.64a 
−77.94b 
10.48±0.25 
P<  0.05a 
P< 0.05b 
−61.25a 
−76.55b 
68.33±0.85 
P< 0.05a 
P< 0.05b 
+109.11a 
+104.62b 
NDN (108) 51.21±0.95 
P< 0.05a 
P< 0.05b 
P> 0.05c 
+145.27a 
+133.74b 
+103.68c 
0.50±0.01 
P< 0.05a 
P< 0.05b 
P> 0.05c 
−70.42a 
−73.52b 
−94.33c 
10.02±0.22 
P< 0.05a 
P< 0.05b 
P> 0.05c 
−58.56a 
−73.19b 
−95.61c 
71.89±0.67 
P< 0.05a 
P< 0.05b 
P< 0.05c 
+114.80a 
+110.07b 
+105.21c 
acompared with control; b compared with DM; c compared with DN 
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(P< 0.05). Similar to our results, Ohtsuki et al.
25
 
presented the increased MDA level because of 
reduced activity of most of the antioxidant enzyme. 
Glutathione is thiol-containing tripeptides which in its 
reduced form (GSH) is present in living cells at  
high concentrations. When it reacts with ROS, it  
gets oxidized to glutathione radical which is 
regenerated to its reduced form through glutathione 
reductase activity. We found a significant decrease  
in GSH concentration in patients’ group which may 
be due to conversion of reduced form to oxidized 
form (GSSH) by excessive production of reactive 
oxygen species. 
SOD catalyzes the superoxide dismutase to H2O2 
which is further diminished by the CAT and 
glutathione peroxidase activity
26,27
. The current  
study demonstrates a significant reduction in SOD 
activity in patients as compared to control. The  
auto oxidation of glucose leads to H2O2 formation, 
which inactivate SOD
28
. Decreased SOD activity 
could be due to ageing in DM patients and it  
may result in increase in the glycation of SOD. 
Ceballos et al.
29
 denoted that during ageing process 
the steady state concentration of H2O2 is found to be 
higher which could increase peroxidation of PUFA  
in cell membrane. It leads to the lysis of erythrocytes 
resulting in the increase in the level of antioxidant 
enzymes like CAT in the extracellular fluid.  
In erythrocytes, H2O2 is mainly detoxified by activity 
of glutathione reductase and peroxidase. When these 
enzymes activity reduces because of poor availability 
of NADPH and GSH, the other enzyme (i.e. CAT) 
expresses and detoxifies the H2O2. Kumar et al.
30
 in 
his studies has shown that decrease in activity of 
glutathione peroxidase, there is compensatory 
increase in the CAT activity. Inal et al.
31
 also reported 
increased activity of CAT with age due to increase 
formation of H2O2. 
Diabetic patients generally have less significant 
plasma antioxidant level with poor glycemic control 
compared to healthy individuals
32
. Oxidative stress in 
DM coexists with a decrease in the antioxidant status, 
which can further increase the harmful effects of  
free radicals
33
. Korkmaz et al.
34
 investigated the  
status of markers of oxidative stress in DM and 
reported a significant reduced level of antioxidant 
power. On the basis of the result obtained they 
concluded that the higher glucose concentration  
escort to tissue injury by increasing oxidative stress. 
Similar to this study, we have found significant 
decrease in SOD activity in patients’ groups compared 
to control group may be due to higher oxidative  
stress produced by higher glucose level (Fig. 1). 
Increased production of oxidants consequential  
from different biochemical pathways (i.e. glucose 
autoxidation, non-enzymatic glycation of proteins  
and activation of protein kinase C activated by 
hyperglycemia) may result in decreased SOD activity. 
Thus, elevated oxidative stress, as well as  
reduced antioxidant capacity may perhaps be 
connected to the complications in patients with 
diabetes such as DN
34
.  
The TNF- α and IL1-α expression profile was 
analyzed for all groups of patients and control by using 
Real time PCR (Fig. 2). The results showed significantly 
increased expression of TNF-α and IL1-α in patients’ 
group compared to unaffected controls after 
normalization with GAPDH expression. It denotes that 
TNF-α and IL1-α play important role in disease 
progression by inducing inflammation. Navarro et al.
35,36
 
has reviewed the importance of TNF-α as therapeutic 
target for DN. Our expression studies data analysis 
indicates that there is significant increase in  
TNF-α transcript levels between control and  
patients group. At the time of stress or any injury  
cell releases IL-1, it stimulates various cell  
protective responses such as establishment of early 
transcription genes that uphold the cell survival and 
proliferation. In experimental models of DN, renal 
expression of IL-1 increases, which is related to 
 
 
Fig. 1 — Correlation between FBS (fasting blood sugar) and  
SOD activity 
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successive expression of chemotaxis factors and 
adhesion molecules
37-39
. 
 
Conclusion 
The current study disclose that hyperglycemia 
produced marked oxidant impact as evidenced by the 
considerable increase in lipid peroxidation products 
(MDA) as well as decrease in antioxidants including 
SOD and GSH content. Patients with high values for 
inflammatory markers have shown increased 
oxidative stress which proves oxidative stress and 
inflammation to be the pivotal pathophysiological 
triggers in DM and DN. Amending these processes 
using restorative methods may restrict the occurrences 
of diabetic complications like DN. 
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